CRBP

Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company located in Norwood, Massachusetts, specializing in the development of innovative therapies that target the endocannabinoid system to tackle pressing unmet medical needs in autoimmunity, fibrosis, and oncology. The company boasts a diverse and promising pipeline aimed at enhancing treatment modalities for chronic diseases, with the potential to reshape patient care paradigms. With its distinct approach to cannabinoid-based therapies, Corbus is strategically poised to attract institutional investors eager to engage with pioneering advancements in the healthcare sector.